Costing and cost-effectiveness of Cepheid Xpert HIV -1 Qual Assay using whole blood protocol versus PCR by Abbott Systems in Malawi.

Maggie Nyirenda Nyang'waGerald ManthaluMatthias ArnoldDominic NkhomaMina C HosseinipourMaganizo ChagomeranaPrecious ChibweKevin MortimerNeil KennedyDerek FairleyVictor MwapasaChisomo MsefulaHenry C MwandumbaJobiba ChinkhumbaNigel KleinDagmar AlberAngela Obasi

Published in: Journal of global health economics and policy (2022)

This preliminary evidence suggests that adopting POCT XpertHIV will save time, allowing HIV-exposed infants to receive prompt care and may improve outcomes. The Malawi government will pay less due to XpertHIV's cost savings and associated benefits.

Keyphrases

antiretroviral therapy
hiv positive
hiv testing
hiv infected
human immunodeficiency virus
hepatitis c virus
hiv aids
men who have sex with men
healthcare
randomized controlled trial
palliative care
south africa
health insurance
type diabetes
metabolic syndrome
insulin resistance